HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Susan B Bressler Selected Research

Verteporfin (Visudyne)

1/2022Timing of Complete Polypoidal Regression after Intravitreous Aflibercept Treatments in Polypoidal Choroidal Vasculopathy.
5/2006Occult with no classic subfoveal choroidal neovascular lesions in age-related macular degeneration: clinically relevant natural history information in larger lesions with good vision from the Verteporfin in Photodynamic Therapy (VIP) Trial: VIP Report No. 4.
9/2005Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: four-year results of an open-label extension of 2 randomized clinical trials: TAP Report No. 7.
4/2005Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trial.
8/2004Retrospective case series of juxtafoveal choroidal neovascularization treated with photodynamic therapy with verteporfin.
4/2004Acute severe visual acuity decrease after photodynamic therapy with verteporfin: case reports from randomized clinical trials-TAP and VIP report no. 3.
3/2004Large submacular hemorrhages after verteporfin therapy.
2/2004Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: meta-analysis of 2-year safety results in three randomized clinical trials: Treatment Of Age-Related Macular Degeneration With Photodynamic Therapy and Verteporfin In Photodynamic Therapy Study Report no. 4.
9/2003Effect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to age-related macular degeneration: TAP and VIP report no. 1.
9/2003Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin: fluorescein angiographic guidelines for evaluation and treatment--TAP and VIP report No. 2.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Susan B Bressler Research Topics

Disease

31Macular Edema
12/2022 - 01/2008
27Macular Degeneration (Age-Related Maculopathy)
01/2022 - 10/2002
21Diabetic Retinopathy (Retinopathy, Diabetic)
12/2021 - 01/2008
19Choroidal Neovascularization
01/2015 - 10/2002
5Cataract (Cataracts)
12/2015 - 11/2009
4Eye Diseases (Eye Disease)
02/2014 - 02/2003
3Geographic Atrophy
02/2014 - 11/2005
3Endophthalmitis (Ophthalmia)
08/2013 - 06/2010
3Hemorrhage
09/2010 - 03/2004
2Retinal Vein Occlusion
12/2022 - 07/2007
2Retinal Detachment (Retinal Detachments)
06/2020 - 11/2005
2Edema (Dropsy)
11/2018 - 03/2004
2Glaucoma
05/2015 - 08/2013
2Vitreous Hemorrhage
08/2013 - 04/2005
2Disease Progression
11/2009 - 05/2006
2Histoplasmosis
04/2005 - 12/2004
2Back Pain (Backache)
02/2004 - 10/2002
1Polypoidal Choroidal Vasculopathy
01/2022
1Open-Angle Glaucoma (Glaucoma, Open Angle)
05/2015
1Retinal Diseases
05/2015
1Telangiectasis (Telangiectasia)
10/2014
1Lung Neoplasms (Lung Cancer)
02/2014
1Blindness (Hysterical Blindness)
06/2012
1Vision Disorders (Hemeralopia)
06/2012
1Epiretinal Membrane (Epiretinal Membranes)
10/2010
1Hypoxia (Hypoxemia)
10/2009
1Central Serous Chorioretinopathy
04/2009
1Microaneurysm
01/2008
1Hematoma
04/2005
1Diabetes Mellitus
03/2004
1Injection Site Reaction
02/2004
1Myopia
04/2003

Drug/Important Bio-Agent (IBA)

19Ranibizumab (Lucentis)FDA Link
01/2022 - 06/2010
18Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022 - 10/2009
14Verteporfin (Visudyne)FDA Link
01/2022 - 10/2002
10Retinaldehyde (Retinal)IBA
01/2015 - 03/2004
10Fluorescein (Funduscein)FDA LinkGeneric
04/2012 - 04/2003
5afliberceptIBA
12/2022 - 01/2016
5Triamcinolone (Aristocort)FDA Link
04/2016 - 07/2008
4Bevacizumab (Avastin)FDA Link
01/2018 - 01/2008
3salicylhydroxamic acid (SHAM)IBA
06/2020 - 06/2011
3Triamcinolone Acetonide (Azmacort)FDA LinkGeneric
08/2013 - 06/2011
2Hemoglobins (Hemoglobin)IBA
11/2018 - 05/2006
2LuteinIBA
02/2014 - 07/2013
2ZeaxanthinsIBA
02/2014 - 07/2013
2Retinal Pigments (Pigments, Visual)IBA
11/2005 - 07/2005
21-phenyl-3,3-dimethyltriazene (PDT)IBA
08/2004 - 04/2004
1Indocyanine Green (Cardio-Green)FDA LinkGeneric
01/2022
1APTIBA
12/2015
1CopperIBA
02/2014
1Ascorbic Acid (Vitamin C)FDA LinkGeneric
02/2014
1ZincIBA
02/2014
1Vitamin EFDA LinkGeneric
02/2014
1beta Carotene (Betacarotene)FDA Link
02/2014
1Green OrIBA
11/2013
1Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
07/2013
1Endothelial Growth FactorsIBA
05/2013
1Angiogenesis InhibitorsIBA
10/2009
1VitaminsIBA
06/2008
1amsonic acid (DAS)IBA
12/2004

Therapy/Procedure

23Therapeutics
06/2020 - 10/2002
15Photochemotherapy (Photodynamic Therapy)
01/2022 - 10/2002
15Lasers (Laser)
12/2021 - 12/2004
15Light Coagulation
06/2020 - 11/2005
6Injections
12/2022 - 06/2011
4Vitrectomy
06/2020 - 10/2010
2Retreatment
01/2016 - 03/2014
2Aftercare (After-Treatment)
01/2015 - 09/2012
1Traction
06/2020
1Intravitreal Injections
08/2013
1Glycemic Control
07/2008
1Hormone Replacement Therapy (Therapy, Hormone Replacement)
02/2005
1Contact Lenses
03/2004
1Ambulatory Care (Outpatient Care)
02/2003